logo

Biotechnology & Drugs News

Share

UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review

Merck: European Commission Approves KEYTRUDA Plus Chemotherapy In Breast Cancer

Roivant Sciences: FDA Approves Dermavant's VTAMA Cream, 1% For Plaque Psoriasis In Adults

SpringWorks Therapeutics Says Nirogacestat Meets Endpoints In Phase 3 DeFi Trial